CENTRALCHINA MT (09982) releases its mid-year performance for 2024, with a net profit of approximately 48.3 million Hong Kong dollars, representing a year-on-year decrease of around 74.7%.
Zhongyuan Jianye (09982) released its performance for the six months ending on June 30, 2024, with the group's revenue totaling 1....
CENTRALCHINA MT (09982) released its performance for the six months ending on June 30, 2024. The group's revenue was RMB 146 million, a year-on-year decrease of 61.8%, and the net profit was approximately HKD 48.3 million, a year-on-year decrease of about 74.7%. Earnings per share were 1.2 cents.
Related Articles
Chifeng Gold (06693) obtains the controlling shareholder Li Jinyang's release of the pledge of 34 million shares of the company.
C-MER MEDICAL (03309) announced on December 29th that it will spend HKD 580,700 to repurchase 340,000 shares.
TRULY INT'L (00732) spent 1.08 million Hong Kong dollars to repurchase 1 million shares on December 29th.
Chifeng Gold (06693) obtains the controlling shareholder Li Jinyang's release of the pledge of 34 million shares of the company.
C-MER MEDICAL (03309) announced on December 29th that it will spend HKD 580,700 to repurchase 340,000 shares.
TRULY INT'L (00732) spent 1.08 million Hong Kong dollars to repurchase 1 million shares on December 29th.
RECOMMEND
Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025
Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025
Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025
